Posaconazole Delayed-Release Tablets and Recombinate
Determining the interaction of Posaconazole Delayed-Release Tablets and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Posaconazole Delayed-Release Tablets-Recombinate recombinant
- Posaconazole Delayed-Release Tablets-Recombivax
- Posaconazole Delayed-Release Tablets-Recombivax HB
- Posaconazole Delayed-Release Tablets-Recombivax HB Adult
- Posaconazole Delayed-Release Tablets-Recombivax HB Dialysis Formulation
- Posaconazole Delayed-Release Tablets-Recombivax HB Pediatric/Adolescent
- Recombinate-Posaconazole Injection
- Recombinate-Posaconazole Intravenous
- Recombinate-Posaconazole Oral Suspension
- Recombinate-Posaconazole oral/injection
- Recombinate-Posaconazole Tablets
- Recombinate-PosiFlush flush